Organon & Co. (OGN) Deferred Federal Income Tax Expense (Benefit) USD 2019 - 2023

Historical data

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred federal income tax expense (benefit) pertaining to income (loss) from continuing operations.
Summary
Organon & Co. annual Deferred Federal Income Tax Expense (Benefit) history and growth rate from 2019 to 2023.
  • Organon & Co. annual Deferred Federal Income Tax Expense (Benefit) for 2023 was -$52 M, a 36.8% decline from 2022.
  • Organon & Co. annual Deferred Federal Income Tax Expense (Benefit) for 2022 was -$38 M, a 40.6% increase from 2021.
  • Organon & Co. annual Deferred Federal Income Tax Expense (Benefit) for 2021 was -$64 M, a 682% decline from 2020.
Deferred Federal Income Tax Expense (Benefit), Annual (USD)
Deferred Federal Income Tax Expense (Benefit), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 -$52 M -$14 M -36.8% Jan 1, 2023 Dec 31, 2023 10-K 2024-02-26
2022 -$38 M +$26 M +40.6% Jan 1, 2022 Dec 31, 2022 10-K 2024-02-26
2021 -$64 M -$75 M -682% Jan 1, 2021 Dec 31, 2021 10-K 2024-02-26
2020 $11 M +$8 M +267% Jan 1, 2020 Dec 31, 2020 10-K 2023-02-27
2019 $3 M Jan 1, 2019 Dec 31, 2019 10-K 2022-03-21
* An asterisk sign (*) next to the value indicates that the value is likely invalid.